Chintagumpala, M., Terhune, C., Tong, L., Bouffet, E., Bartels, U., Fisher, M., … Gajjar, A. (2020). FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. In Neuro Oncology (Vol. 22, pp. 394–394).

Chintagumpala, Murali, Colton Terhune, Lin Tong, Eric Bouffet, Ute Bartels, Michael Fisher, Tim Hassall, et al. “FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY.” In Neuro Oncology, 22:394–394, 2020.

Chintagumpala M, Terhune C, Tong L, Bouffet E, Bartels U, Fisher M, et al. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. In: Neuro Oncology. 2020. p. 394–394.

Chintagumpala, Murali, et al. “FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY.” Neuro Oncology, vol. 22, 2020, pp. 394–394.

Chintagumpala M, Terhune C, Tong L, Bouffet E, Bartels U, Fisher M, Hassall T, Gururangan S, Schroeder K, Hansford J, Quang DAK, Cohn R, Kellie S, McCowage G, Smith K, Northcott P, Robinson G, Gajjar A. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. Neuro Oncology. 2020. p. 394–394.